In a clinical trial, 23 out of 870 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.4% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.4% of this drug's users experience flulike symptoms as a side effect at the α=0.05 level of significance?
Because np0(1−p0)=__?__
▼
<
>
≠
=
10, the sample size is
▼
less than
greater than
5% of the population size, and the sample
▼
can be reasonably assumed to be random,
is given to be random,
cannot be reasonably assumed to be random,
is given to not be random,
the requirements for testing the hypothesis
▼
are not
are
satisfied.
(Round to one decimal place as needed.)
np0(1−p0) = 20.3788 > 10 the sample size is greater than 5% of the population size, and the sample can be reasonably assumed to be random, is given to be random the requirements for testing the hypothesis are not satisfied.
Z = 0.4 ( one decimal place )
P value = 0.4 ( one decimal place )
Calculations :
Z critical = 1.645 > Z stat
Do not reject null hypothesis
there is no sufficient evidence to conclude that more than 2.4% of this drug's users experience flulike symptoms as a side effect at the α=0.05 level of significance
In a clinical trial, 23 out of 870 patients taking a prescription drug daily complained of...
In a clinical trial, 22 out of 897 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.1% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.1% of this drug's users experience flulike symptoms as a side effect at the a = 0.01 level of significance? less than 5% of the population size, and the sample can be reasonably assumed to be random,...
In a clinical trial, 24 out of 893 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.4% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.4% of this drug's users experience flulike symptoms as a side effect at the a=0.1 level of significance? V 5% of the population size, and the sample the requirements for testing the hypothesis satisfied. Because np. (1-P)...
In a clinical trial, 23 out of 888 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.1% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.1% of this drug's users experience flulike symptoms as a side effect at the a = 0.1 level of significance? of the population size, and the sample the requirements for testing the hypothesis Because np 10, the...
In a clinical trial, 18 out of 853 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.8% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 1.8% of this drug's users experience flulike symptoms as a side effect at the a = 0.01 level of significance? Because npo (1 - Po) 10, the sample size is 5% of the population size, and the...
In a clinical trial, 18 out of 858 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.8% of patients taking competing drugs complain of ulike symptoms. Is there sufficient evidence to conclude that more than 1.8% of this drug's users experience flulike symptoms as a side effect at the a=0.05 level of significance? 5% of the population size, and the sample V the Because npo (1-P) - 10, the sample size is...
In a clinical trial, 19 out of 892 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.9% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 1.9% of this drug's users experience flulike symptoms as a side effect at the alpha equals α=0.05 level of significance?
In a clinical trial, 25 out of 857 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.4% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.4% of this drug's users experience fiulike symptoms as a side effect at the a=0.05 level of significance? Because np. (1-Po) - 10. the sample size is 5% of the population size, and the sample the requirements...
X 10.2.17-T Question Helo In a clinical trial, 27 out of 866 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 26% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.6% of this drug's users experience flulike symptoms as a side effect at the x = 0.05 level of significance? Because npo (1-P) - 866 = 10, the sample size is less than...
In a clinical trial, 20 out of 600 patients taking a prescription drug complained of flulike symptoms. Suppose that it is known that 5.5 % of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that less than 5 % of this drug's users experience flulike symptoms as a side effect at the α=0.04 level of significance? A. Construct the null hypothesis and the alternative hypothesis. B. What is the P-value of the test result?...
In a clinical trial, 18 out of 840 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.8% of patients taking competing drugs complain of Puike symptoms. Is there sufficient evidence to conclude that more than 1.8% of this drug's users experience fiulike symptoms as a side effect at the a= 0.05 level of significance? Because np. (1-P) O10, the sample size is 5% of the population size, and the sample the requirements...